KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Minority Interest: 2017-2019

Historic Minority Interest for BeOne Medicines (ONC) over the last 3 years, with Dec 2019 value amounting to $16.1 million.

  • BeOne Medicines' Minority Interest fell 42.76% to $9.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $9.0 million, marking a year-over-year decrease of 42.76%. This contributed to the annual value of $16.1 million for FY2019, which is 11.80% up from last year.
  • BeOne Medicines' Minority Interest amounted to $16.1 million in FY2019, which was up 11.80% from $14.4 million recorded in FY2018.
  • In the past 5 years, BeOne Medicines' Minority Interest ranged from a high of $16.1 million in FY2019 and a low of $14.4 million during FY2017.
  • Over the past 3 years, BeOne Medicines' median Minority Interest value was $14.4 million (recorded in 2018), while the average stood at $15.0 million.
  • Data for BeOne Medicines' Minority Interest shows a peak YoY climbed of 11.80% (in 2019) over the last 5 years.
  • Over the past 3 years, BeOne Medicines' Minority Interest (Yearly) stood at $14.4 million in 2017, then increased by 0.16% to $14.4 million in 2018, then climbed by 11.80% to $16.1 million in 2019.